Dendreon
id:
dendreon-183-14572793
title:
Dendreon
text:
Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge, is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells that have been incubated with the Dendreon PAP-GM-CSF fusion protein.
Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by t
brand slug:
wiki
category slug:
encyclopedia
description:
Biotechnology company
original url:
https://en.wikipedia.org/wiki/Dendreon
date created:
2006-10-06T02:31:46Z
date modified:
2024-09-06T21:59:02Z
main entity:
{"identifier":"Q5256667","url":"https://www.wikidata.org/entity/Q5256667"}
image:
fields total:
13
integrity:
15